Mammary-specific ablation of Cyp24a1 inhibits development, reduces proliferation and increases sensitivity to vitamin D.

作者: Lei Sheng , Andrew G. Turner , Kate Barratt , Richard Kremer , Howard A. Morris

DOI: 10.1016/J.JSBMB.2019.01.005

关键词:

摘要: Active vitamin D (1,25(OH)2D) has been shown to regulate numerous cell processes in mammary cells. Degradation of 1,25(OH)2D is initiated by the mitochondrial enzyme, 25-hydroxyvitamin 24-hydroxylase (CYP24 A1), and provides local control bioactivity. Several reports association between elevated CYP24 A1 activity breast cancer incidence, suggest that may be a target for therapeutic intervention. Whether within epithelium regulates levels gland development yet shown. We have used conditional knockout Cyp24a1 gene specifically demonstrate reduced terminal end bud number, ductal outgrowth branching during puberty alveologenesis at early pregnancy, inhibiting proliferation but not apoptosis both basal luminal MECs. In vitro study showed increased sensitivity MECs lower with ablation activity. summary, plays an important role modulating postnatal pregnancy-associated which support as potential approach activating pathway prevention therapy.

参考文章(37)
Lorraine Lowe, Christina MØrk Hansen, Siddhika Senaratne, Kay W. Colston, Mechanisms implicated in the growth regulatory effects of vitamin D compounds in breast cancer cells. Recent results in cancer research. ,vol. 164, pp. 99- 110 ,(2003) , 10.1007/978-3-642-55580-0_6
Donna G. Albertson, Bauke Ylstra, Richard Segraves, Colin Collins, Shanaz H. Dairkee, David Kowbel, Wen-Lin Kuo, Joe W. Gray, Daniel Pinkel, Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nature Genetics. ,vol. 25, pp. 144- 146 ,(2000) , 10.1038/75985
Nair Lopes, Bárbara Sousa, Diana Martins, Madalena Gomes, Daniella Vieira, Luiz A Veronese, Fernanda Milanezi, Joana Paredes, José L Costa, Fernando Schmitt, Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions Vitamin D pathways unbalanced in breast lesions BMC Cancer. ,vol. 10, pp. 483- 483 ,(2010) , 10.1186/1471-2407-10-483
Rachel J. Suetani, Kristen Ho, Shalini Jindal, Jim Manavis, Paul M. Neilsen, Kathleen I. Pishas, Elisabeth Rippy, Melissa Bochner, James Kollias, P. Grantley Gill, Howard A. Morris, David F. Callen, A comparison of vitamin D activity in paired non-malignant and malignant human breast tissues Molecular and Cellular Endocrinology. ,vol. 362, pp. 202- 210 ,(2012) , 10.1016/J.MCE.2012.06.022
Aruna V. Krishnan, Srilatha Swami, David Feldman, The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer. Steroids. ,vol. 77, pp. 1107- 1112 ,(2012) , 10.1016/J.STEROIDS.2012.06.005
Gerard A Tarulli, Duvini De Silva, Victor Ho, Kamini Kunasegaran, Kakaly Ghosh, Bryan C Tan, Dmitry V Bulavin, Alexandra M Pietersen, Hormone-sensing cells require Wip1 for paracrine stimulation in normal and premalignant mammary epithelium. Breast Cancer Research. ,vol. 15, pp. 1- 17 ,(2013) , 10.1186/BCR3381
David Feldman, Aruna V. Krishnan, Srilatha Swami, Edward Giovannucci, Brian J. Feldman, The role of vitamin D in reducing cancer risk and progression Nature Reviews Cancer. ,vol. 14, pp. 342- 357 ,(2014) , 10.1038/NRC3691
Lisa M. Davis, Cole Harris, Lei Tang, Patti Doherty, Peter Hraber, Yumiko Sakai, Therese Bocklage, Katie Doeden, Bryan Hall, John Alsobrook, Ian Rabinowitz, Thomas M. Williams, John Hozier, Amplification Patterns of Three Genomic Regions Predict Distant Recurrence in Breast Carcinoma The Journal of Molecular Diagnostics. ,vol. 9, pp. 327- 336 ,(2007) , 10.2353/JMOLDX.2007.060079
Xinjian Peng, Michael Hawthorne, Avani Vaishnav, René St-Arnaud, Rajendra G. Mehta, 25-Hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ culture. Breast Cancer Research and Treatment. ,vol. 113, pp. 31- 41 ,(2009) , 10.1007/S10549-008-9900-0